89bio, Inc. Files 8-K on Operations and Financials
| Field | Detail |
|---|---|
| Company | 89bio, Inc. |
| Form Type | 8-K |
| Filed Date | Aug 7, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-condition, operations
TL;DR
89bio filed an 8-K, check it for financial and operational updates.
AI Summary
On August 7, 2025, 89bio, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This filing indicates that 89bio, Inc. is providing updates on its financial performance and operational status to the SEC, which is important for investors to monitor company health.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report for operational and financial updates, not indicating any immediate or specific risks.
Key Players & Entities
- 89bio, Inc. (company) — Registrant
- August 7, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Francisco, CA (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing by 89bio, Inc.?
The primary purpose of this 8-K filing is to report on 89bio, Inc.'s results of operations and financial condition, as well as to provide financial statements and exhibits.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on August 7, 2025.
In which state was 89bio, Inc. incorporated?
89bio, Inc. was incorporated in Delaware.
What is the address of 89bio, Inc.'s principal executive offices?
The address of 89bio, Inc.'s principal executive offices is 655 Montgomery Street, Suite 1500, San Francisco, CA 94111.
What is the telephone number for 89bio, Inc.?
The telephone number for 89bio, Inc. is (415) 432-9270.
Filing Stats: 476 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-08-07 16:17:20
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share ETNB The Nasdaq Global Ma
Filing Documents
- d915354d8k.htm (8-K) — 25KB
- d915354dex991.htm (EX-99.1) — 46KB
- g915354dsp1.jpg (GRAPHIC) — 9KB
- 0001193125-25-175445.txt ( ) — 202KB
- etnb-20250807.xsd (EX-101.SCH) — 3KB
- etnb-20250807_lab.xml (EX-101.LAB) — 18KB
- etnb-20250807_pre.xml (EX-101.PRE) — 11KB
- d915354d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits . The following exhibits are being furnished herewith: EXHIBIT INDEX Exhibit No. Description 99.1 Press Release, dated August 7, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 89bio, Inc. Date: August 7, 2025 By: /s/ Rohan Palekar Rohan Palekar Chief Executive Officer